16-56887057-C-T

Variant summary

Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_001126108.2(SLC12A3):​c.2142C>T​(p.Ala714Ala) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.105 in 1,613,796 control chromosomes in the GnomAD database, including 10,144 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.12 ( 1169 hom., cov: 31)
Exomes 𝑓: 0.10 ( 8975 hom. )

Consequence

SLC12A3
NM_001126108.2 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:10

Conservation

PhyloP100: -4.10
Variant links:
Genes affected
SLC12A3 (HGNC:10912): (solute carrier family 12 member 3) This gene encodes a renal thiazide-sensitive sodium-chloride cotransporter that is important for electrolyte homeostasis. This cotransporter mediates sodium and chloride reabsorption in the distal convoluted tubule. Mutations in this gene cause Gitelman syndrome, a disease similar to Bartter's syndrome, that is characterized by hypokalemic alkalosis combined with hypomagnesemia, low urinary calcium, and increased renin activity associated with normal blood pressure. This cotransporter is the target for thiazide diuretics that are used for treating high blood pressure. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.66).
BP6
Variant 16-56887057-C-T is Benign according to our data. Variant chr16-56887057-C-T is described in ClinVar as [Benign]. Clinvar id is 255884.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-56887057-C-T is described in Lovd as [Benign].
BP7
Synonymous conserved (PhyloP=-4.1 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.218 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SLC12A3NM_001126108.2 linkc.2142C>T p.Ala714Ala synonymous_variant Exon 17 of 26 ENST00000563236.6 NP_001119580.2 P55017-1
SLC12A3NM_000339.3 linkc.2142C>T p.Ala714Ala synonymous_variant Exon 17 of 26 NP_000330.3 P55017-2
SLC12A3NM_001126107.2 linkc.2139C>T p.Ala713Ala synonymous_variant Exon 17 of 26 NP_001119579.2 P55017-3
SLC12A3NM_001410896.1 linkc.2139C>T p.Ala713Ala synonymous_variant Exon 17 of 26 NP_001397825.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SLC12A3ENST00000563236.6 linkc.2142C>T p.Ala714Ala synonymous_variant Exon 17 of 26 1 NM_001126108.2 ENSP00000456149.2 P55017-1
SLC12A3ENST00000438926.6 linkc.2142C>T p.Ala714Ala synonymous_variant Exon 17 of 26 1 ENSP00000402152.2 P55017-2
SLC12A3ENST00000566786.5 linkc.2139C>T p.Ala713Ala synonymous_variant Exon 17 of 26 1 ENSP00000457552.1 P55017-3
SLC12A3ENST00000262502.5 linkc.2139C>T p.Ala713Ala synonymous_variant Exon 17 of 26 5 ENSP00000262502.5 J3QSS1

Frequencies

GnomAD3 genomes
AF:
0.117
AC:
17764
AN:
152062
Hom.:
1163
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.128
Gnomad AMI
AF:
0.113
Gnomad AMR
AF:
0.177
Gnomad ASJ
AF:
0.0997
Gnomad EAS
AF:
0.230
Gnomad SAS
AF:
0.159
Gnomad FIN
AF:
0.0934
Gnomad MID
AF:
0.0981
Gnomad NFE
AF:
0.0890
Gnomad OTH
AF:
0.128
GnomAD3 exomes
AF:
0.129
AC:
32336
AN:
251230
Hom.:
2581
AF XY:
0.124
AC XY:
16901
AN XY:
135860
show subpopulations
Gnomad AFR exome
AF:
0.129
Gnomad AMR exome
AF:
0.220
Gnomad ASJ exome
AF:
0.102
Gnomad EAS exome
AF:
0.227
Gnomad SAS exome
AF:
0.152
Gnomad FIN exome
AF:
0.0987
Gnomad NFE exome
AF:
0.0875
Gnomad OTH exome
AF:
0.117
GnomAD4 exome
AF:
0.104
AC:
151448
AN:
1461616
Hom.:
8975
Cov.:
34
AF XY:
0.104
AC XY:
75907
AN XY:
727110
show subpopulations
Gnomad4 AFR exome
AF:
0.124
Gnomad4 AMR exome
AF:
0.218
Gnomad4 ASJ exome
AF:
0.0997
Gnomad4 EAS exome
AF:
0.253
Gnomad4 SAS exome
AF:
0.152
Gnomad4 FIN exome
AF:
0.0962
Gnomad4 NFE exome
AF:
0.0893
Gnomad4 OTH exome
AF:
0.112
GnomAD4 genome
AF:
0.117
AC:
17785
AN:
152180
Hom.:
1169
Cov.:
31
AF XY:
0.120
AC XY:
8938
AN XY:
74394
show subpopulations
Gnomad4 AFR
AF:
0.128
Gnomad4 AMR
AF:
0.178
Gnomad4 ASJ
AF:
0.0997
Gnomad4 EAS
AF:
0.229
Gnomad4 SAS
AF:
0.158
Gnomad4 FIN
AF:
0.0934
Gnomad4 NFE
AF:
0.0890
Gnomad4 OTH
AF:
0.130
Alfa
AF:
0.0968
Hom.:
1032
Bravo
AF:
0.123
Asia WGS
AF:
0.185
AC:
642
AN:
3478
EpiCase
AF:
0.0872
EpiControl
AF:
0.0933

ClinVar

Significance: Benign
Submissions summary: Benign:10
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Familial hypokalemia-hypomagnesemia Benign:4
Jul 10, 2021
Genome-Nilou Lab
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Jun 29, 2017
Athena Diagnostics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Sep 16, 2020
Natera, Inc.
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

not specified Benign:3
-
PreventionGenetics, part of Exact Sciences
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

not provided Benign:3
Sep 29, 2019
GeneDx
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.66
CADD
Benign
0.28
DANN
Benign
0.61

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs5803; hg19: chr16-56920969; COSMIC: COSV52635223; API